WALTHAM, Mass. -- Decision Resources, Inc., one of
the world's leading research and advisory firms focusing on pharmaceutical and
health care issues, finds that pressure from expert panels, payers, and public
health officials to reduce antibiotic overprescribing will limit growth of the
acute exacerbations of chronic bronchitis (AECB) drug market over the next
decade.
"AECB is currently overtreated with antibiotics, and experts suggest that
a subset of patients with minor symptoms probably do not require antibiotic
therapy," said Aarti Raja, PhD, an analyst at Decision Resources. "However,
because AECB patients often have multiple other medical problems, primary care
physicians tend to err on the side of caution and prescribe antibiotics-often
the 'latest and greatest'."
The new Pharmacor study, titled Acute Exacerbations of Chronic Bronchitis,
also finds that physicians are caught between a need to limit overprescribing
and a need to deal with increasing antibiotic resistance among respiratory
pathogens in the major pharmaceutical markets (United States, Germany, France,
Italy, Spain, Japan, and the United Kingdom). So far, attempts by managed care
organizations, insurers, and national health systems to contain the cost of
treating AECB have been thwarted in part by these new generations of resistant
bacteria.
During an acute exacerbation, breathing becomes much more difficult
because of further narrowing of the airways and secretion of large amounts of
mucus that is often thicker than usual. An acute exacerbation of chronic
bronchitis is associated with increased frequency and severity of coughing,
and is often accompanied by worsened chest congestion and discomfort.
Source: Decision Resources, Inc.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.